Symbols / DXCM Stock $68.92 -0.22% DexCom, Inc.

Healthcare • Medical Devices • United States • NMS
DXCM (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Jacob Steven Leach
Exch · Country NMS · United States
Market Cap 26.59B
Enterprise Value 25.56B
Income 930.40M
Sales 4.82B
FCF (ttm) 1.06B
Book/sh 7.66
Cash/sh 6.26
Employees 11,000
Insider 10d —
IPO Apr 14, 2005
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 29.58
Forward P/E 22.36
PEG 1.29
P/S 5.52
P/B 9.00
P/C —
EV/EBITDA 19.78
EV/Sales 5.31
Quick Ratio 1.58
Current Ratio 1.95
Debt/Eq 46.83
LT Debt/Eq —
EPS (ttm) 2.33
EPS next Y 3.08
EPS Growth 92.20%
Revenue Growth 15.00%
EPS Gr Q/Q 89.30%
Rev Gr Q/Q —
Earnings (next) 2026-07-29
Earnings (prior) 2026-04-30
ROA 9.65%
ROE 35.62%
ROIC —
Gross Margin 61.50%
Oper. Margin 21.42%
Profit Margin 19.31%
Shs Outstand 385.87M
Shs Float 384.50M
Insider Own 0.28%
Instit Own 102.46%
Short Float 5.19%
Short Ratio 2.38
Short Interest 17.39M
52W High 89.98
vs 52W High -23.41%
52W Low 54.11
vs 52W Low 27.37%
Beta 1.44
Impl. Vol. 50.34%
Rel Volume 1.12
Avg Volume 5.49M
Volume 6.16M
Target (mean) $85.21
Tgt Median $85.00
Tgt Low $65.00
Tgt High $112.00
# Analysts 24
Recom Strong_buy
Prev Close $69.07
Price $68.92
Change -0.22%
About

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$85.21
Mean price target
2. Current target
$68.92
Latest analyst target
3. DCF / Fair value
$49.29
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$68.92
Low
$65.00
High
$112.00
Mean
$85.21

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-06-23 init Deutsche Bank Buy → Buy $86
2026-06-15 main Piper Sandler Overweight → Overweight $88
2026-06-10 main TD Cowen Buy → Buy $95
2026-06-09 main Mizuho Outperform → Outperform $85
2026-06-05 main Stifel Buy → Buy $90
2026-05-28 main Citigroup Buy → Buy $84
2026-05-18 main Canaccord Genuity Buy → Buy $82
2026-05-18 main B of A Securities Buy → Buy $80
2026-05-18 main Barclays Underweight → Underweight $64
2026-05-04 main Citigroup Buy → Buy $79
2026-05-01 main Canaccord Genuity Buy → Buy $100
2026-05-01 main TD Cowen Buy → Buy $75
2026-05-01 main Barclays Underweight → Underweight $67
2026-03-11 main Citigroup Buy → Buy $84
2026-03-09 reit BTIG Buy → Buy $85
2026-02-25 reit BTIG Buy → Buy $85
2026-02-17 reit Truist Securities Buy → Buy $80
2026-02-13 main Canaccord Genuity Buy → Buy $95
2026-02-13 main Barclays Underweight → Underweight $72
2026-02-13 main Wells Fargo Overweight → Overweight $85
News
RSS: Latest DXCM news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-06-15 BROWN MICHAEL JON Officer — 1,700 $75.55 $128,435
2026-06-15 FOLETTA MARK G Director — 4,000 $74.10 $296,540
2026-06-04 COLEMAN JON Officer — 9,823 $73.00 $722,628
2026-05-28 DRISCOLL RIMMA Director — 5,605 $0.00 $0
2026-05-28 ASHLEY EUAN A. Director — 5,565 $0.00 $0
2026-05-28 COLLINS RICHARD ALEXANDER Director — 5,605 $0.00 $0
2026-05-28 MALADY KYLE Director — 5,575 $0.00 $0
2026-05-28 GALA RENEE D Director — 5,605 $0.00 $0
2026-05-28 AUGUSTINOS NICHOLAS Director — 5,575 $0.00 $0
2026-05-28 ALTMAN STEVEN R Director — 5,565 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
4,662.00
+15.60%
4,033.00
+11.34%
3,622.30
+24.49%
2,909.80
Operating Revenue
4,662.00
+15.60%
4,033.00
+11.34%
3,622.30
+24.49%
2,909.80
Cost Of Revenue
1,860.10
+16.64%
1,594.80
+19.60%
1,333.40
+29.87%
1,026.70
Reconciled Cost Of Revenue
1,860.10
+16.64%
1,594.80
+19.60%
1,333.40
+29.87%
1,026.70
Gross Profit
2,801.90
+14.92%
2,438.20
+6.52%
2,288.90
+21.55%
1,883.10
Operating Expense
1,890.10
+2.82%
1,838.20
+8.69%
1,691.20
+13.36%
1,491.90
Research And Development
599.10
+8.45%
552.40
+9.21%
505.80
+4.46%
484.20
Selling General And Administration
1,291.00
+0.40%
1,285.80
+8.47%
1,185.40
+17.63%
1,007.70
Total Expenses
3,750.20
+9.24%
3,433.00
+13.50%
3,024.60
+20.09%
2,518.60
Operating Income
911.80
+51.97%
600.00
+0.38%
597.70
+52.79%
391.20
Total Operating Income As Reported
911.80
+51.97%
600.00
+0.38%
597.70
+52.79%
391.20
EBITDA
1,358.50
+43.65%
945.70
+3.16%
916.70
+62.16%
565.30
Normalized EBITDA
1,358.50
+43.65%
945.70
+3.16%
916.70
+62.16%
565.30
Reconciled Depreciation
251.80
+15.66%
217.70
+17.04%
186.00
+19.31%
155.90
EBIT
1,106.70
+52.02%
728.00
-0.37%
730.70
+78.48%
409.40
Total Unusual Items
—
—
0.00
0.00
Total Unusual Items Excluding Goodwill
—
—
0.00
0.00
Special Income Charges
—
—
0.00
0.00
Other Special Charges
—
—
—
—
Net Income
836.30
+45.14%
576.20
+6.41%
541.50
+58.70%
341.20
Pretax Income
1,088.40
+53.51%
709.00
-0.20%
710.40
+81.78%
390.80
Net Non Operating Interest Income Expense
94.40
-18.06%
115.20
+0.44%
114.70
+2105.77%
5.20
Interest Expense Non Operating
18.30
-3.68%
19.00
-6.40%
20.30
+9.14%
18.60
Net Interest Income
94.40
-18.06%
115.20
+0.44%
114.70
+2105.77%
5.20
Interest Expense
18.30
-3.68%
19.00
-6.40%
20.30
+9.14%
18.60
Interest Income Non Operating
112.70
-16.02%
134.20
-0.59%
135.00
+467.23%
23.80
Interest Income
112.70
-16.02%
134.20
-0.59%
135.00
+467.23%
23.80
Other Income Expense
82.20
+1425.81%
-6.20
-210.00%
-2.00
+64.29%
-5.60
Other Non Operating Income Expenses
4.10
+185.42%
-4.80
-23.08%
-3.90
+30.36%
-5.60
Tax Provision
252.10
+89.83%
132.80
-21.37%
168.90
+240.52%
49.60
Tax Rate For Calcs
0.00
+23.86%
0.00
-21.22%
0.00
+87.33%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
836.30
+45.14%
576.20
+6.41%
541.50
+58.70%
341.20
Net Income From Continuing Operation Net Minority Interest
836.30
+45.14%
576.20
+6.41%
541.50
+58.70%
341.20
Net Income From Continuing And Discontinued Operation
836.30
+45.14%
576.20
+6.41%
541.50
+58.70%
341.20
Net Income Continuous Operations
836.30
+45.14%
576.20
+6.41%
541.50
+58.70%
341.20
Normalized Income
836.30
+45.14%
576.20
+6.41%
541.50
+58.70%
341.20
Net Income Common Stockholders
836.30
+45.14%
576.20
+6.41%
541.50
+58.70%
341.20
Diluted EPS
2.09
+47.18%
1.42
+9.23%
1.30
+58.54%
0.82
Basic EPS
2.14
+46.58%
1.46
+4.29%
1.40
+59.09%
0.88
Basic Average Shares
390.20
-0.86%
393.60
+1.97%
386.00
-0.87%
389.40
Diluted Average Shares
405.50
-1.74%
412.70
-3.01%
425.50
-0.47%
427.50
Diluted NI Availto Com Stockholders
847.30
+44.17%
587.70
+6.06%
554.10
+57.33%
352.20
Average Dilution Earnings
11.00
-4.35%
11.50
-8.73%
12.60
+14.55%
11.00
Amortization
—
—
—
7.50
Amortization Of Intangibles Income Statement
—
—
—
7.50
Depreciation Amortization Depletion Income Statement
—
—
—
7.50
Depreciation And Amortization In Income Statement
—
—
—
7.50
Earnings From Equity Interest
78.10
+5678.57%
-1.40
-173.68%
1.90
+850.00%
0.20
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
6,339.90
-2.23%
6,484.50
+3.51%
6,264.50
+16.19%
5,391.70
Current Assets
4,033.30
-6.23%
4,301.40
-2.81%
4,425.90
+20.64%
3,668.80
Cash Cash Equivalents And Short Term Investments
1,998.70
-22.51%
2,579.40
-5.31%
2,724.10
+10.91%
2,456.20
Cash And Cash Equivalents
917.70
+51.41%
606.10
+7.03%
566.30
-11.83%
642.30
Other Short Term Investments
1,081.00
-45.22%
1,973.30
-8.55%
2,157.80
+18.96%
1,813.90
Receivables
1,289.90
+23.53%
1,044.20
+5.74%
987.50
+31.28%
752.20
Accounts Receivable
1,216.10
+20.92%
1,005.70
+3.27%
973.90
+36.53%
713.30
Gross Accounts Receivable
1,228.60
+21.06%
1,014.90
+3.22%
983.20
+36.44%
720.60
Allowance For Doubtful Accounts Receivable
-12.50
-35.87%
-9.20
+1.08%
-9.30
-27.40%
-7.30
Taxes Receivable
73.80
+91.69%
38.50
+183.09%
13.60
-65.04%
38.90
Inventory
629.10
+15.94%
542.60
-3.04%
559.60
+82.46%
306.70
Raw Materials
257.60
-21.25%
327.10
+2.38%
319.50
+100.94%
159.00
Work In Process
105.00
+273.67%
28.10
-6.33%
30.00
+74.42%
17.20
Finished Goods
266.50
+42.21%
187.40
-10.80%
210.10
+61.00%
130.50
Prepaid Assets
66.40
-24.11%
87.50
-2.99%
90.20
-22.71%
116.70
Current Deferred Assets
20.00
+7.53%
18.60
+22.37%
15.20
+49.02%
10.20
Other Current Assets
29.20
+0.34%
29.10
-40.97%
49.30
+83.96%
26.80
Total Non Current Assets
2,306.60
+5.66%
2,183.10
+18.74%
1,838.60
+6.72%
1,722.90
Net PPE
1,637.30
+16.72%
1,402.70
+18.42%
1,184.50
+4.31%
1,135.60
Gross PPE
2,496.10
+19.95%
2,081.00
+22.85%
1,693.90
+13.02%
1,498.80
Accumulated Depreciation
-858.80
-26.61%
-678.30
-33.16%
-509.40
-40.25%
-363.20
Properties
0.00
0.00
0.00
0.00
Land And Improvements
58.30
+9.79%
53.10
+53.91%
34.50
+28.25%
26.90
Buildings And Improvements
319.70
+9.86%
291.00
+52.76%
190.50
+250.83%
54.30
Machinery Furniture Equipment
1,145.10
+11.64%
1,025.70
+30.50%
786.00
+48.13%
530.60
Construction In Progress
593.50
+67.37%
354.60
+8.08%
328.10
-39.53%
542.60
Other Properties
77.40
+23.25%
62.80
-12.04%
71.40
-10.75%
80.00
Leases
302.10
+2.83%
293.80
+3.67%
283.40
+7.19%
264.40
Goodwill And Other Intangible Assets
95.00
-24.72%
126.20
-20.98%
159.70
-19.75%
199.00
Goodwill
24.20
+6.14%
22.80
-9.52%
25.20
-1.95%
25.70
Other Intangible Assets
70.80
-31.53%
103.40
-23.12%
134.50
-22.39%
173.30
Investments And Advances
218.00
+82.73%
119.30
+209.87%
38.50
+102.63%
19.00
Non Current Deferred Assets
295.60
-38.57%
481.20
+14.74%
419.40
+22.92%
341.20
Non Current Deferred Taxes Assets
295.60
-38.57%
481.20
+14.74%
419.40
+22.92%
341.20
Non Current Prepaid Assets
17.20
+24.64%
13.80
-4.17%
14.40
-11.11%
16.20
Other Non Current Assets
43.50
+9.02%
39.90
+80.54%
22.10
+85.71%
11.90
Total Liabilities Net Minority Interest
3,593.90
-17.98%
4,381.90
+4.43%
4,195.90
+28.71%
3,259.90
Current Liabilities
2,142.50
-26.93%
2,932.00
+88.43%
1,556.00
-15.40%
1,839.30
Payables And Accrued Expenses
2,058.60
+25.45%
1,641.00
+11.63%
1,470.10
+48.74%
988.40
Payables
380.20
-1.91%
387.60
+18.71%
326.50
+15.49%
282.70
Accounts Payable
344.30
-0.29%
345.30
+24.93%
276.40
+16.18%
237.90
Current Accrued Expenses
1,678.40
+33.91%
1,253.40
+9.60%
1,143.60
+62.05%
705.70
Pensionand Other Post Retirement Benefit Plans Current
34.60
-7.73%
37.50
+20.19%
31.20
-16.80%
37.50
Total Tax Payable
35.90
-15.13%
42.30
-15.57%
50.10
+11.83%
44.80
Income Tax Payable
8.90
+128.21%
3.90
-48.00%
7.50
-41.86%
12.90
Current Debt And Capital Lease Obligation
21.60
-98.24%
1,226.90
+5714.69%
21.10
-97.34%
793.10
Current Debt
—
1,204.40
—
772.60
Other Current Borrowings
—
1,204.40
—
772.60
Current Capital Lease Obligation
21.60
-4.00%
22.50
+6.64%
21.10
+2.93%
20.50
Current Deferred Liabilities
27.70
+4.14%
26.60
-20.83%
33.60
+65.52%
20.30
Current Deferred Revenue
7.70
-3.75%
8.00
-56.52%
18.40
+82.18%
10.10
Other Current Liabilities
—
—
—
—
Total Non Current Liabilities Net Minority Interest
1,451.40
+0.10%
1,449.90
-45.08%
2,639.90
+85.83%
1,420.60
Long Term Debt And Capital Lease Obligation
1,368.10
+0.56%
1,360.50
-47.12%
2,572.90
+90.32%
1,351.90
Long Term Debt
1,240.90
+0.32%
1,237.00
-49.18%
2,434.20
+103.24%
1,197.70
Long Term Capital Lease Obligation
127.20
+3.00%
123.50
-10.96%
138.70
-10.05%
154.20
Long Term Provisions
20.60
+21.18%
17.00
+8.28%
15.70
+41.44%
11.10
Tradeand Other Payables Non Current
46.60
+4.02%
44.80
+15.76%
38.70
+18.35%
32.70
Non Current Deferred Liabilities
—
9.50
+28.38%
7.40
-61.05%
19.00
Non Current Deferred Revenue
—
9.50
+28.38%
7.40
-61.05%
19.00
Non Current Deferred Taxes Liabilities
—
—
—
4.90
Other Non Current Liabilities
16.10
-41.67%
27.60
+430.77%
5.20
-11.86%
5.90
Stockholders Equity
2,746.00
+30.60%
2,102.60
+1.64%
2,068.60
-2.96%
2,131.80
Common Stock Equity
2,746.00
+30.60%
2,102.60
+1.64%
2,068.60
-2.96%
2,131.80
Capital Stock
0.40
+0.00%
0.40
+0.00%
0.40
+0.00%
0.40
Common Stock
0.40
+0.00%
0.40
+0.00%
0.40
+0.00%
0.40
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
410.70
+0.44%
408.90
+0.42%
407.20
+3.56%
393.20
Ordinary Shares Number
384.80
-1.51%
390.70
+1.38%
385.40
-0.23%
386.30
Treasury Shares Number
25.90
+42.31%
18.20
-16.51%
21.80
+215.94%
6.90
Additional Paid In Capital
2,281.50
+8.96%
2,093.80
-40.43%
3,514.60
+55.64%
2,258.10
Retained Earnings
2,433.90
+52.35%
1,597.60
+56.41%
1,021.40
+112.84%
479.90
Gains Losses Not Affecting Retained Earnings
115.00
+1537.50%
-8.00
+52.10%
-16.70
-43.97%
-11.60
Treasury Stock
2,084.80
+31.85%
1,581.20
-35.49%
2,451.10
+311.95%
595.00
Other Equity Adjustments
115.00
+1537.50%
-8.00
+52.10%
-16.70
-43.97%
-11.60
Total Equity Gross Minority Interest
2,746.00
+30.60%
2,102.60
+1.64%
2,068.60
-2.96%
2,131.80
Total Capitalization
3,986.90
+19.38%
3,339.60
-25.83%
4,502.80
+35.24%
3,329.50
Working Capital
1,890.80
+38.08%
1,369.40
-52.28%
2,869.90
+56.87%
1,829.50
Invested Capital
3,986.90
-12.26%
4,544.00
+0.91%
4,502.80
+9.77%
4,102.10
Total Debt
1,389.70
-46.29%
2,587.40
-0.25%
2,594.00
+20.93%
2,145.00
Net Debt
323.20
-82.39%
1,835.30
-1.75%
1,867.90
+40.66%
1,328.00
Capital Lease Obligations
148.80
+1.92%
146.00
-8.64%
159.80
-8.53%
174.70
Net Tangible Assets
2,651.00
+34.13%
1,976.40
+3.54%
1,908.90
-1.24%
1,932.80
Tangible Book Value
2,651.00
+34.13%
1,976.40
+3.54%
1,908.90
-1.24%
1,932.80
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
1,440.70
+45.60%
989.50
+32.20%
748.50
+11.80%
669.50
Cash Flow From Continuing Operating Activities
1,440.70
+45.60%
989.50
+32.20%
748.50
+11.80%
669.50
Net Income From Continuing Operations
836.30
+45.14%
576.20
+6.41%
541.50
+58.70%
341.20
Depreciation Amortization Depletion
251.80
+15.66%
217.70
+17.04%
186.00
+19.31%
155.90
Depreciation
219.00
+20.86%
181.20
+22.93%
147.40
+2.29%
144.10
Amortization Cash Flow
32.80
-10.14%
36.50
-5.44%
38.60
+227.12%
11.80
Depreciation And Amortization
251.80
+15.66%
217.70
+17.04%
186.00
+19.31%
155.90
Amortization Of Intangibles
32.80
-10.14%
36.50
-5.44%
38.60
+227.12%
11.80
Other Non Cash Items
-14.50
+64.81%
-41.20
+45.86%
-76.10
-286.52%
40.80
Stock Based Compensation
159.60
-6.34%
170.40
+13.00%
150.80
+19.21%
126.50
Deferred Tax
182.20
+515.98%
-43.80
+20.36%
-55.00
-154.63%
-21.60
Deferred Income Tax
182.20
+515.98%
-43.80
+20.36%
-55.00
-154.63%
-21.60
Operating Gains Losses
-78.10
-5678.57%
1.40
+173.68%
-1.90
-850.00%
-0.20
Gain Loss On Investment Securities
—
—
-1.90
-850.00%
-0.20
Unrealized Gain Loss On Investment Securities
—
—
—
—
Change In Working Capital
103.40
-4.96%
108.80
+3300.00%
3.20
-88.01%
26.70
Change In Receivables
-201.90
-476.86%
-35.00
+86.54%
-260.10
-30.12%
-199.90
Changes In Account Receivables
-201.90
-476.86%
-35.00
+86.54%
-260.10
-30.12%
-199.90
Change In Inventory
-63.70
-613.71%
12.40
+104.91%
-252.60
-612.37%
49.30
Change In Prepaid Assets
-14.80
-155.17%
-5.80
-130.05%
19.30
+114.67%
-131.60
Change In Payables And Accrued Expense
402.40
+165.26%
151.70
-69.88%
503.70
+65.91%
303.60
Change In Accrued Expense
55.40
+192.33%
-60.00
-261.29%
37.20
+337.65%
8.50
Change In Payable
347.00
+63.91%
211.70
-54.62%
466.50
+58.08%
295.10
Change In Account Payable
347.00
+63.91%
211.70
-54.62%
466.50
+58.08%
295.10
Change In Other Working Capital
-18.60
-28.28%
-14.50
-104.23%
-7.10
-233.96%
5.30
Investing Cash Flow
536.00
+358.31%
-207.50
+59.09%
-507.20
+2.74%
-521.50
Cash Flow From Continuing Investing Activities
536.00
+358.31%
-207.50
+59.09%
-507.20
+2.74%
-521.50
Net PPE Purchase And Sale
-363.50
-1.31%
-358.80
-51.65%
-236.60
+35.14%
-364.80
Purchase Of PPE
-363.50
-1.31%
-358.80
-51.65%
-236.60
+35.14%
-364.80
Capital Expenditure
-363.50
-1.31%
-358.80
-51.65%
-236.60
+35.14%
-364.80
Net Investment Purchase And Sale
898.90
+438.91%
166.80
+161.21%
-272.50
-78.10%
-153.00
Purchase Of Investment
-1,265.80
+52.37%
-2,657.60
+17.46%
-3,219.90
-41.17%
-2,280.80
Sale Of Investment
2,164.70
-23.36%
2,824.40
-4.17%
2,947.40
+38.52%
2,127.80
Net Business Purchase And Sale
—
0.00
0.00
+100.00%
-3.90
Purchase Of Business
—
0.00
0.00
+100.00%
-3.90
Net Other Investing Changes
0.60
+103.87%
-15.50
-915.79%
1.90
+850.00%
0.20
Financing Cash Flow
-1,686.40
-129.50%
-734.80
-130.63%
-318.60
+42.33%
-552.50
Cash Flow From Continuing Financing Activities
-1,686.40
-129.50%
-734.80
-130.63%
-318.60
+42.33%
-552.50
Net Issuance Payments Of Debt
-1,207.50
0.00
-100.00%
443.30
0.00
Issuance Of Debt
0.00
0.00
-100.00%
1,230.60
0.00
Repayment Of Debt
-1,207.50
0.00
+100.00%
-787.30
0.00
Long Term Debt Issuance
0.00
0.00
-100.00%
1,230.60
0.00
Long Term Debt Payments
-1,207.50
0.00
+100.00%
-787.30
0.00
Net Long Term Debt Issuance
-1,207.50
0.00
-100.00%
443.30
0.00
Net Common Stock Issuance
-471.90
+34.62%
-721.80
-9.02%
-662.10
-23.71%
-535.20
Common Stock Payments
-500.00
+33.33%
-750.00
-8.90%
-688.70
-23.49%
-557.70
Repurchase Of Capital Stock
-500.00
+33.33%
-750.00
-8.90%
-688.70
-23.49%
-557.70
Net Other Financing Charges
-7.00
+46.15%
-13.00
+86.97%
-99.80
-476.88%
-17.30
Changes In Cash
290.30
+515.04%
47.20
+161.06%
-77.30
+80.89%
-404.50
Effect Of Exchange Rate Changes
21.50
+390.54%
-7.40
-593.33%
1.50
+125.86%
-5.80
Beginning Cash Position
607.30
+7.01%
567.50
-11.78%
643.30
-38.94%
1,053.60
End Cash Position
919.10
+51.34%
607.30
+7.01%
567.50
-11.78%
643.30
Free Cash Flow
1,077.20
+70.79%
630.70
+23.21%
511.90
+68.00%
304.70
Interest Paid Supplemental Data
11.40
+0.00%
11.40
-8.06%
12.40
+1.64%
12.20
Income Tax Paid Supplemental Data
94.40
-52.32%
198.00
-6.74%
212.30
+85.90%
114.20
Common Stock Issuance
28.10
-0.35%
28.20
+6.02%
26.60
+18.22%
22.50
Earnings Losses From Equity Investments
-78.10
-5678.57%
1.40
+173.68%
-1.90
—
Issuance Of Capital Stock
28.10
-0.35%
28.20
+6.02%
26.60
+18.22%
22.50
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category